Needham & Company is raising their price target on Seattle Genetics (Nasdaq: SGEN) from $16 to $18, following results from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE